mdlinx mdlinx
Latest (24) Full Text Articles (547) Article Summary

The combination of exposure-response and case-control analyses in regulatory decision making
The Journal of Clinical Pharmacology,

Yang J et al. – The identified subgroup without survival benefit and the exposure–response (ER) relationship support the recommendation on conducting clinical trials to identify a treatment regimen with greater exposure and acceptable safety profiles and to prospectively evaluate whether this treatment regimen will result in survival benefit for the identified subgroup.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pharma News

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pharma News Articles

Last month's top read Top Articles of 2013

1 Rentschler announces 3rd industrial cell culture technology conference on processes for virus-based biologics Full Text B3C newswire, March 17, 2014    Free full text

2 Treatment for rare metabolic disease approved Full Text Drug Topics, March 3, 2014    Free full text

3 GSK and Theravance announce positive results from studies comparing ANORO ELLIPTA with SERETIDE DISKUS and ADVAIR DISKUS in patients with COPD Full Text GlaxoSmithKline, March 17, 2014    Free full text

4 FDA details national vaccine plan Full Text BioPharm International, March 12, 2014    Free full text

5 Ranbaxy suspends API shipments from two plants in India Full Text BioPharm International, February 26, 2014    Free full text

6 First U.S. clinical site opens for CEL-SCIS global phase III immunotherapy head and neck cancer trial expansion Full Text CEL-SCI, March 5, 2014    Free full text

7 Biotechnology industry prospects remain strong Full Text First Report Managed Care, March 21, 2014    Free full text

8 Merck announces results from phase 2b study of MK-8237, an investigational house dust mite sublingual allergen immunotherapy tablet Full Text Merck, March 5, 2014    Free full text

9 Hailey-Hailey disease responding to thalidomide Full Text Indian Journal of Dermatology, March 6, 2014    Free full text

10 What do pharmas "High Performers" have in common? Full Text Pharmaceutical Executive Magazine, March 10, 2014    Free full text

11 Bristol-Myers Squibb presents promising phase IIb data for novel, investigational attachment inhibitor for HIV-1 infected treatment-experienced patients Full Text Bristol Myers-Squibb, March 7, 2014    Free full text

12 Formycon AG: Licensing out of the first biosimilar development project already enables extension of the product pipeline as of 2014 Full Text B3C newswire, March 13, 2014    Free full text

13 FDA allows marketing of first medical device to prevent migraine headaches Full Text FDA Press Announcements, March 13, 2014    Free full text

14 Sirturo (bedaquiline) receives conditional approval in the European union for the treatment of multi-drug resistant tuberculosis Full Text Johnson & Johnson, March 7, 2014    Free full text

15 AAAAI 2014ASTHMA: New phase III data show tiotropium respimat effective across asthma severities Full Text Boehringer Ingelheim, March 3, 2014    Free full text

16 Sanofis board of directors propose appointment of Patrick Kron as new independent director Full Text Sanofi, March 6, 2014    Free full text

17 Research and publication trends in hospital medicine Journal of Hospital Medicine, March 11, 2014    Evidence Based Medicine

18 Fda approves vibativ for hospitalized patients with bacterial pneumonia Full Text FDA Press Announcements, June 25, 2013    Free full text

19 FDA releases guidance on CMC postapproval changes Full Text BioPharm International, March 5, 2014    Free full text

20 UPLC system for nano- to microscale separations Full Text BioPharm International, March 19, 2014    Free full text

Indexed Journals in Pharma News: U.S.Pharmacist, FDA Drug Alerts, Pharmiwebmore

Other Topics in Pharma News

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register
Upcoming Clinical Trials UPCOMING Clinical Trials

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close